Introduction
============

*Amorpha fruticosa* L. (Fabaceae) is known by several common names, *viz.* false indigo-bush, desert false indigo, and bastard indigobush, which refer to its traditional use as a dye source. The plant is a shrub native to North America -- contiguous United States, northern Mexico, and south-eastern Canada ([@B123]; [@B116]; [@B4]). A mature plant has a broad crown with 1--10 stems growing to a height of 1.0--3.5 m and it is highly variable in morphology. The morphological variety of the plant is reflected by the fact that the species' currently accepted name has at least 16 synonyms ([@B26]). The leaves are compound, odd-pinnate, 10--28 cm long with 9--21 leaflets that are 2--4 cm long and 1--2 cm wide. In the northern hemisphere, *A. fruticosa* blooms May and June with scented flowers that are purplish blue with orange anthers and occur in upright spikes. Linnaeus called this plant *Amorpha* because the flower has only a single petal (flag), while the other four petals that are normally present in legumes are entirely missing ([@B7]). The flowers are followed by fruits which mature in July and August. The fruits are short, smooth or hairy, glandular legumes containing one or two smooth brownish seeds ([@B29]; [@B26]). The rich nectar production of these flowers with ten protruding stamens with yellow anthers makes false indigo, a highly appreciated honey plant and important food source for bees, both in its native range and in the invaded territories ([@B87]; [@B65]; [@B108]; [@B85]; [@B105]; [@B112]; [@B114]; [@B43]; [@B42]; [@B28]; [@B47]).

*Amorpha fruticosa* became popular in Europe as ornamental plant in the early 1700s ([@B48]; [@B7]). Its role as a honey plant also contributed to its cultivation ([@B51]). Additionally, it was planted to stabilize the soil (especially on railway embankments) due to its protective role against erosion provided by an extensive root system ([@B117]; [@B11]; [@B14]). As a result of all these human activities *A. fruticosa* is registered among the worst Alien Invasive Species Inventories for Europe ([@B22]) and the detrimental effects of the plant on local biospheres have been investigated in several case studies ([@B110]; [@B25]; [@B83]; [@B91]; [@B22]; [@B97]; [@B88]). *A. fruticosa* can also tolerate dry soils, but it is most abundant along river banks and roads and the edges of flooded forests. The plant grows well in medium to wet, well-drained, soils in full sun to light shade and is tolerant of occasional flooding. It has well-developed roots and is relatively wind-tolerant. It may spread by self-seeding and/or suckers to form thickets ([@B34]). This high tolerance of various habitat conditions and potent propagation ability promotes the aggressive invasive behavior of *A. fruticosa* outside of its native range. *A. fruticosa* is especially successful in colonizing degraded habitats (e.g., areas where agriculture or grazing has been abandoned), but it also invades natural plant communities, where it competes with native vegetation leading to a considerable increase in activity, density, and abundance of soil invertebrates, but at the same time it massively decreases species diversity ([@B14]). Interestingly, the invasiveness of *A. fruticosa* has also been attributed to its allelopathic potential in terms of a so-called juglone index ([@B109]) that was found to be highest in a study comparing fifteen invasive plant species occurring in Hungary ([@B19]; [@B20]). *A. fruticosa* invasion was observed to considerably affect carabid beetle species composition although these insects are known to be only indirectly related to plant composition ([@B14]). Often the organisms that are predators on the invasive plants in the natural habitats are not present in the newly invaded habitats. Thus, the control of the populations is reduced which promotes the distribution of the invasive plants and jeopardizes the ecological balance. In the case of *A. fruticosa* the North American bruchid beetle *Acanthoscelides pallidipennis* (Motschulsky), the larvae of which feed in seeds, has been found in some of the invaded territories (Kyushu Island, Japan) and it could help to re-establish ecological balance. However, the effectiveness of such seed predators as natural enemies of invasive plant species is controversial ([@B113]), and *A. fruticosa* remains amongst the most dangerous invasive species in Europe ([@B22]; [@B97]; [@B88]). At the same time, many examples reveal the effective destructive power of mankind when plants are used commercially. Exploitation of the populations of invasive plant species for medicinal purposes may be regarded as regulation ecosystem services and part of a sustainable development strategy. Such a strategy could contribute to balance the natural ecosystems and preserve biodiversity.

One of the quite promising medical applications of *A. fruticosa* is against diabetic complications. Diabetes is a serious, chronic disease caused by either insufficient insulin production from the pancreas (type 1), or when the body cannot effectively utilize the insulin it produces (type 2) ([@B124]). Diabetes is one of the most important public health problems of our time, and its prevalence has been increasing over the past few decades. According to the World Health Organisation reports, the global prevalence of diabetes has doubled since 1980, rising from 4.7 to 8.5% in the adult population ([@B125]). Diabetes leads to severe complications including diabetic neuropathy, diabetic micro and macro angiopathy, diabetic nephropathy and diabetic retinopathy. Further long-term complications with diabetes include cardiovascular disease, leg amputations, stroke, chronic renal failure, vision loss, and nerve damage.

Diabetic retinopathy is responsible for about 2.6% of blindness ([@B10]). At least 80% of the end stage renal disease is caused by diabetes, hypertension or a combination of them, while the proportion attributed solely to diabetes ranges between 12% and 55% ([@B115]). The risk of cardiovascular disease development elevates with rising fasting plasma glucose levels, even at lower values than those that meet the criteria for a diabetes diagnosis ([@B23]; [@B101]). Amputations among the people with diabetes are typically 10 to 20 times more frequent than among the non-diabetic population ([@B80]).

Diabetes directly caused 1.5 million deaths in 2012, and 2.2 million people died from additional complications, yielding 3.7 million deaths in a single year from a single disease. Forty-three percent of them occurred before the age of 70 ([@B125]).

Therefore, diabetes is among the chief priorities in most of the health systems around the world. While type 1 diabetes is not preventable with current medical knowledge, there are different approaches to prevent type 2, and to minimize the complications and the premature death caused by all types of diabetes.

The vast majority of the cases with diabetes are type 2 ([@B124]). There are several known risk factors that contribute to developing type 2 diabetes such as ethnicity, family history, smoking, older age etc. but the most important of them is excess body fat (obesity) ([@B36]).

According to the estimations, the direct cost of diabetes to the world is more than 827 billion USD per year ([@B98]; [@B84]).

Metabolic syndrome is defined as a condition characterized by a variety of diagnostic criteria, most important of which are obesity, dyslipidaemia, type 2 diabetes and arterial hypertension. All of them contribute to an elevated risk of cardiovascular morbidity and mortality. Several different diagnostic sets of criteria exist: from the World Health Organization ([@B2]), from the [@B49], from the European Group for the study of Insulin Resistance ([@B8]), the National Cholesterol Education Programme Adult Treatment Panel III ([@B33]), as well as from the American Association of Clinical Endocrinologists ([@B32]).

The cardiovascular risk increases continuously with the number of the syndrome components present ([@B3]), and the cumulative risk of the concurrent factors is greater than that of the individual risk factors alone ([@B93]).

Plants have been a continuous source of therapeutic agents historically, and still today represent a valuable pool for the discovery and development of new therapeutics in general ([@B6]), as well as in the context of cardiovascular and metabolic disease in particular ([@B119]).

Due to the fact that *Amorpha fruticosa* is a successful aggressive invasive species, it could provide a vast and cheap resource of plant chemical constituents which can be utilized for remedial purposes. Additionally, problems which this plant causes to the natural habitats in many European countries could be alleviated. The aim of this study is to review the plant chemical constituents and the potential of *Amorpha fruticosa* against diabetes and metabolic syndrome. In the context of safety in a possible medical application, considerations regarding a potential toxicity of *A. fruticosa* are also discussed.

Ethnobotanical use of *Amorpha fruticosa*
=========================================

Native Americans of the Great Plains employed several of the more common *Amorpha* species for a variety of uses. *Amorpha fruticosa* was used for bedding material, horse feed, arrow shafts, the stems were arranged on the ground to create a clean surface on which to put butchered meat, and name "false indigo" is related to the application of the plant as a blue dye ([@B46]; [@B39], [@B40]; [@B102]; [@B118]; [@B82]; [@B62]; [@B7]; [@B107]). For medicinal purposes such as stomach pain, intestinal worms, eczema, neuralgia, and rheumatism, the related species *A. canescens* was used and its powdered leaves were applied to wounds ([@B46]; [@B39], [@B40]; [@B102], [@B107]). Moreover, reports for medicinal use of *Amorpha fruticosa* are also available: The Seminoles used infusion from leaves and stems as a general tonic and also against rheumatism and chronic sickness together with other plants; the Omaha used the plant to cure wounds ([@B82]; [@B7]).

Phytochemical Constituents of *Amorpha fruticosa*
=================================================

Typically for a leguminous plant, *Amorpha* contains a set of family marker classes such as isoflavonoids and their derivatives called rotenoids (**Figure [1](#F1){ref-type="fig"}** and **Table [1](#T1){ref-type="table"}**), which result from the formation of an additional oxygen ring between rings B and C of the isoflavone skeleton ([@B18]; [@B44]). Like many other specialized metabolites, flavonoids (**Figure [2](#F2){ref-type="fig"}** and **Table [2](#T2){ref-type="table"}**) and rotenoids undergo further structural modifications after biosynthesis, which include prenylation, esterification, methylation, and addition of other various moieties.
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###### 

List of rotenoids isolated from various parts of *Amorpha fruticosa* plant.

                                                                                                                                                                                                                Contents or obtained
  --------------- --------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------- ------------ ----------------------
  **Rotenoids**                                                                                                                                                                                                 
  1               Amorphigenin (8′ hydroxyrotenone)                                                                                                                   4208-09-7                    L, S, R      0.65
  2               12β-Hydroxyamorphigenin                                                                                                                             85042-77-9                   A            n.a
  3               6a,12a-Dehydro-3-*O*-demethylamorphigenin                                                                                                           not assigned                 F            n.a.
  4               (6aR,12aR,5′R)-Amorphigenin                                                                                                                         stereoisomer of 1            F            0.05
  5               Rotenone                                                                                                                                            83-79-4                      F            0.01
  6               Dalbinol                                                                                                                                            41993-79-7                   F, R         0.745
  7               Rotenolone                                                                                                                                          509-96-6                     F            n.a
  8               11-Hydroxyrotenone/(-)sumatrol                                                                                                                      82-10-0                      F            n.a.
  9               6a*R*, 12a*R*-dalbinol (same as 6)                                                                                                                  41993-79-7                   S            1.49
  10              6a*S*, 12a*S*-Dalbinol                                                                                                                              stereoisomer of 6            S            0.02
  11              3-*O*-Demethyldalbinol                                                                                                                              stereoisomer of 98619-30-8   F            n.a.
  12              12a-Hydroxydalpanol                                                                                                                                 85042-77-9                   A, S         0.13
  13              6′-*O*-β-D-Glucopyranosyldalpanol                                                                                                                   52059-86-6                   A            n.a.
  14              Dalpanol                                                                                                                                            30462-22-7                   F            0.02
  15              6′-*O*-β-D-Glucopyranosyl-12a-hydroxydalpanol                                                                                                                                    F            n.a.
  16              Amorphaside A                                                                                                                                       1703757-00-9                 S            0.62
  17              Amorphaside B                                                                                                                                       1703757-01-0                 S            0.02
  18              Amorphaside C                                                                                                                                       1703757-02-1                 S            0.09
  19              Amorphaside D                                                                                                                                       82873-12-9                   S            0.86
  20              Dalbin                                                                                                                                              68401-03-6                   S            0.41
  21              Amorphin                                                                                                                                            4207-90-3                    S            0.26
  22              Benzopyran-12-one,1,4,10,11-tetrahydro-6′-\[8′-(hydroxymethyl)ethenyl\]-2,3-dimethoxy-8′-*O*-β-D-glucopyranosyl-*O*-α-[D]{.smallcaps}-arabinoside   an enantiomer of amorphin,   A            n.a.
  23              Amorphispironone                                                                                                                                    139006-28-3                  L, F, S, T   0.03
  24              1a*R*,6a*S*,12a*R*-11-Hydroxyamorphispironone                                                                                                       n.a.                         L, T         
  25              Amorphispironone B                                                                                                                                  n.a                          F            0.06
  26              Amorphispironone C                                                                                                                                                               F            0.045
  27              Hydroxyamorphispironone                                                                                                                                                          F            0.21
  28              Tephrosin                                                                                                                                           76-80-2                      L, T         n.a
  29              11-Hydroxytephrosin                                                                                                                                 72458-85-6                   L, T         n.a.
  30              (-)Deguelin                                                                                                                                         522-17-8                     L, F, T      0.036
  31              Sermundone                                                                                                                                          41630-82-4                   F            0.05
  32              Rot-2′-enonic acid                                                                                                                                  70191-71-8                   F            0.009
  33              α-Toxicarol                                                                                                                                         82-09-7                      F            0.014
  34              6a,12a-Dehydrodeguelin                                                                                                                              3466-23-7                    F            n.a
  35              6a,12a-Dehydroamorphigenin                                                                                                                          29444-01-7                   R            n.a.
  36              6-Deoxyclitoriacetal                                                                                                                                146163-05-5                  F            n.a.
  37              Mundoserone                                                                                                                                         3564-85-0                    F            n.a
  38              12a-Hydroxymunduserone                                                                                                                              66280-24-8                   S            0.2
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###### 

Isoflavonoids (non-rotenoid) and other flavonoids isolated from various parts of *Amorpha fruticosa* plant.

                                                                                                                                                                                     Contents or obtained
  --------------------------------- ----------------------------------------------------------------------------------------------------------------------- -------------- --------- ----------------------
  **Other isoflavonoids**                                                                                                                                                            
  39                                Afrormosin                                                                                                              550-79-8       A         n.a
  40                                7,2′,4′,5′-Tetramethoxyisoflavone                                                                                       4253-02-5      A         n.a.
  41                                8-*O*-Methylretusin                                                                                                     37816-20-9     A         n.a
  42                                Ononin                                                                                                                  486-62-4       S         0.02
  43                                Isoformonentin                                                                                                          486-63-5       S         0.01
  44                                Daidzein                                                                                                                486-66-8       S         0.02
  45                                Prunetin                                                                                                                552-59-0       S         0.01
  46                                Pratensein                                                                                                              2284-31-3      S         0.01
  47                                7-Hydroxy-2′,4′,5′-trimethoxyisoflavone                                                                                 29096-94-4     S         0.01
  48                                7-*O*-β-[D]{.smallcaps}-Glucopyranosyl-7-hydroxy-2′,4′,5′-trimethoxyisoflavone                                          Not assigned   S         0.4
  49                                8-Geranyl-5,7,3′-trihydroxy-4′-methoxyisoflavone                                                                        Not assigned   F         0.25
  50                                8-Geranyl-7,3′-dihydroxy-4′-methoxyisoflavone                                                                           Not assigned   F         
  51                                6-Geranyl-5,7,3′-trihydroxy-4′-methoxyisoflavone                                                                        Not assigned   F         0.087
  52                                Daidzein 7-*O*-β-D-glucopyranosyl-(1→2)-[B]{.smallcaps}-D-glucopyranoside                                               Not assigned   F         0.036
  53                                Formononetin                                                                                                            485-72-3       R         n.a
  54                                Calycosin                                                                                                               20575-57-9     R         n.a.
  55                                Amorphaquinone                                                                                                          70283-29-3     R         n.a.
  **Flavones**                                                                                                                                                                       
  56                                3,5,7-Trihydroxy-8-C-geranyl-flavanone                                                                                  Not assigned   F         0.025
  57                                resokaempferol 3-*O*-[B]{.smallcaps}-Dglucopyranosyl-(1→2)-β-D-Glucopyranoside-7-*O*-[L]{.smallcaps}-rhamnopyranoside   Not assigned   F         0.01
  **Prenylflavanones from roots**                                                                                                                                                    
  58                                Amorin                                                                                                                  119347-09-0    R         n.a
  59                                Isoamorin                                                                                                               119347-11-4    R         n.a.
  60                                Amorisin                                                                                                                83474-70-8     R         n.a.
  61                                Amoradicin                                                                                                              83677-03-6     R         n.a
  62                                Amoricin                                                                                                                119347-01-2    R         n.a.
  63                                Isoamoritin                                                                                                             212069-24-4    R         n.a.
  64                                Amorinin                                                                                                                83677-05-8     R         n.a
  65                                Amoradin                                                                                                                119347-05-6    R         n.a.
  66                                Amoradinin                                                                                                              94927-38-5     R         n.a.
  67                                Amorilin                                                                                                                83474-69-5     R         n.a
  68                                Amoritin                                                                                                                83474-68-4     R         n.a.
  **Chalcones**                                                                                                                                                                      
  69                                Xanthoangelol                                                                                                           62949-76-2     L, F, T   0.023
  70                                2′-Methoxyisoliquiritigenin                                                                                             112408-67-0    L, T      n.a.
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Prenylated stilbenoids (**Figure [3](#F3){ref-type="fig"}** and **Table [3](#T3){ref-type="table"}**) are the second important group of phenolic compounds from *Amorpha*. Several previously unreported derivatives of dihydrostilbene (with various substitutions of the bibenzyl skeleton -- depicted in **Figure [3](#F3){ref-type="fig"}**) have recently been isolated and received a lot of attention as potent antidiabetic agents (via binding to PPARγ, see section on pharmacology) ([@B122]; [@B120]; [@B35]). Further, other phenylpropanoids have been identified as plant constituents along with volatile terpenoids and fatty oils. Interestingly, some of the compounds detected or even isolated from this plant are quite rare or even, at the moment, unique in *A. fruticosa* and have not yet been detected in any other plant species. For example, in their recent paper [@B81] report the isolation and structural elucidation of 14 new compounds, which are mainly rotenoids and geranyl-isoflavones, along with 40 known compounds.
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###### 

Stilbenoid compounds, puerarol, and examples of major essential oil constituents from various parts of *Amorpha fruticosa*.

                                                                                                                            Contents or obtained
  -------------------------------------- ------------------------------------------------------ -------------- ------------ ----------------------
  **Stilbenoids**                                                                                                           
  71                                     Pinosylvin                                             22139-77-1     L            n.a
  72                                     2-Carboxy-3,5-dihydroxy-4-geranylbibenzyl                             F            2.7
  73                                     Amorfrutin A                                           80489-90-3     F            1.22
  74                                     Amorfrutin B                                           78916-42-4     F, S         1.58, 0.38
  75                                     2-Carboxy-3-methoxy-5-hydroxy-4-prenylbibenzyl         Not assigned   L, T         n.a
  76                                     2-Carboxy-5-hydroxy-3-methoxy-4-geranylbibenzyl        Not assigned   L, T         n.a.
  77                                     2-Carboxy-3,5-dihydroxy-4-geranylbibenzyl              73436-04-1     L, T         0.018
  78                                     2-\[(Z)-styryl\]-5-geranylresorcin-1-carboxylic acid   Not assigned   F            n.a
  79                                     2-\[(E)-styryl\]-5-geranylresorcin-1-carboxylic acid   Not assigned   F            n.a.
  80                                     Amorfrutin D                                           Not assigned   F            0.04
  81                                     4-*O*-Demethylamorfrutin D                             Not assigned   F            0.05
  82                                     Amorphastilbol                                         72165-33-4     L, T, F      n.a
  83                                     2-Geranyl-5-\[(Z)-styryl\]resorcin                     Not assigned   F            0.036
  84                                     2-Geranyl-5-(2-phenylethyl) resorcin                   Not assigned   F            0.007
  **Other**                                                                                                                 
  85                                     (+) Puerol A                                           1803270-52-1                0.036
  **Major essential oil constituents**   Contents in essential oil %                                                        
  86                                     γ-Cadinene, (sesquiterpene)                            39029-41-9     F            3-11%
  87                                     Δ-Cadinene, (sesquiterpene)                            483-76-1       F            5.7-13-18%
  88                                     β-Elemol                                               32142-08-8     L, flowers   29.4%, 0.14%
  89                                     (-)γ-Amorphene                                         6980-46-7      F            1.3-4.6%
  90                                     ar-Curcumene                                           644-30-4       F            3.0-18.7%
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Phytochemical Constituents of *Amorpha fruticosa*: Isoflavonoids (Including Rotenoids)
======================================================================================

The history of *A. fruticosa* as a subject of interest for phytochemists can be traced back to the beginning of the 20th century. The first pure isoflavonoid to be isolated from *A. fruticosa* was the hydroxyrotenone glycoside amorphin (**21**), which was isolated along with its aglycone back in the 1940s ([@B1]). Since then, more than fifty different compounds belonging to the rotenoid group have been identified in *A. fruticosa* ([@B44]; [@B61]; [@B81]).

A wealth of phytochemical information about phytochemicals in various plant parts of *A. fruticosa* is available from scientists from Uzbekistan, who published their results in the 1960s and 1970s of the last century. They report isolation of rotenoid glycosides and aglycones, such as amorphigenin (**1**), amorphin (**21** -- arabinoglucoside of **1**) and their dehydro- and hydroxy- analogs ([@B63]; [@B55], [@B56], [@B57]; [@B37]; [@B54]; [@B59]).

For isolation of the major glycoside -- amorphin (also known as fruticin, frutitsin, amorphigenin-*O*-vicianoside, where 'vicianoside' refers to α-[L]{.smallcaps}-arabinopyranosyl-1→6-*O*-β-[D]{.smallcaps}-glucopyranoside), simple solvent extraction and subsequent crystallization from the washed precipitate is reported as sufficient to isolate most of the compound contained in the seeds (about 1.5%) and recrystallization yields high purity amorphin corresponding to 0.7% dry mass of the seeds. Subsequently, a series of papers on isolation of the same and some new rotenoids followed, usually applying conventional column chromatography on various stationary phases complemented with preparative or semi-preparative HPLC ([@B64]; [@B111]; [@B66],[@B67]; [@B61]; [@B127]; [@B81]).

The isolates were mostly various analogs of rotenone or amorphigenin as well as spironone type rotenoids, the backbones of which differ in the configuration of oxygen B and E-rings (**Figure [1](#F1){ref-type="fig"}**) ([@B44]). Several glycosides of the above were also obtained, usually of [D]{.smallcaps}-glucose and [L]{.smallcaps}-arabinose. One of these compounds was isolated from fruits by [@B27] and identified as a new, apparently an amorphigenin-*O*- β-[D]{.smallcaps}-glucopyranosyl-α-[D]{.smallcaps}-arabinopyranoside. The only difference between this new compound and the major compound amorphin (amorphigenin-*O*-β-[D]{.smallcaps}-glucopyranosyl-α-[L]{.smallcaps}-arabinopyranoside) is a different stereochemistry of the arabinose-moiety. This compound's identity would have to be confirmed.

Rotenoid aglycons show complex stereochemistry and interestingly the hitherto isolated compounds are often single stereoisomers (for example compounds **6/9/10**, **2/12**, or **21/22**). The stereochemistry of these compounds should be further explored for its influence on pharmacological properties. Moreover, stereospecificity (or its absence) of biosynthetic routes (enzymes) would be important to understand how the proportions between individual compounds are regulated on a quantitative level.

Several isoflavonoid glycosides and aglycones were isolated along with rotenoids. From the bark, four 7-*O*-β-[D]{.smallcaps}-glucopyranosides were obtained with the following aglycones: 4′-methoxyisoflavone, 3′-hydroxy-4′-methoxyisoflavone, 3′,5-dihydroxy-4′-methoxyisoflavone and 4′,6-dimethoxyisoflavone ([@B66]). In seeds, different aglycons such as afrormosin (**39**), 7,2′,4′,5′-tetramethoxyisoflavone (**40**), 8-methylretusin (**41**) isoformononetin (**43**), daidzein (**44**), prunetin (**45**), pratensein (**46**), and glycosides ononin (**42**) and 7-*O*-β-[D]{.smallcaps}-glucopyranoside of **47** (**48**) were found ([@B126]), while in fruits, geranylated aglycones (**49-51**) and a daidzein β-sophoroside (**52**) have been identified ([@B81]). In roots, formononetin (**53**), calycosin (**54**) and a rare quinone isoflavonoid -- amorphaquinone (**55**) have been observed ([@B100]; [@B86]).

A couple of rotenoids and highly prenylated flavonoids were also obtained from root bark ([@B95], [@B96], [@B94]; [@B86]; [@B61]). These are mostly flavanones with two to three isoprenyl chains usually attached to carbons C6, C8 or C5' and sometimes forming additional oxygen rings with adjacent hydroxyls. Most of these prenylflavanones (compounds **58--68**) were unique for roots and have not been reported to be present in aerial parts of *A. fruticosa* so far.

However, despite numerous reports on isolation and bioactivity of a range of rotenoids, it is difficult to find any comprehensive analytic method that would facilitate uniform, comparative profiling and quantitation of possibly all described compounds from *A. fruticosa*.

[@B61] report HPLC analysis of eight isoflavonoids (among which are three rotenoids), which were isolated from a root acetone extract. A triprenylflavanone isoamoritin (**63**) and dalbinol (**6 -** a rotenoid) constituted most of the acetone extract from the root bark. These results suggest that the phytochemical profile of roots is markedly different from leaves or fruits/seeds.

[@B21] used routine UV-HPLC on a C18 column for quantitative analysis of 15 phenolic compounds that they had isolated from leaves and compared their content in three samples of *A. fruticosa*. However, among those compounds, only two rotenoids (tephrosin **28** and 6a,12a-dehydrodeguelin **34**) were included, along with seven common flavonoids, two sterols, two isoflavonoids, and two phenol carboxylic acids.

Phytochemical Constituents of *Amorpha fruticosa*: Stilbenoids
==============================================================

More than 10 stilbene derivatives (**71--84**, **Figure [3](#F3){ref-type="fig"}** and **Table [3](#T3){ref-type="table"}**) have been identified to date in *A. fruticosa*. Depending on saturation of the C-C bond between the two aryls, they either belong to typical stilbenes or, if the two carbon link is saturated, to bibenzyls. The latter group, known as amorfrutins is quite diverse in Amorpha, with a carboxyl moiety attached to the aromatic ring and significant variation of prenylation pattern. Amorfrutins, despite being known as present in *A. fruticosa* already since the 1980s ([@B78], [@B77]), only recently received a lot of attention due to discovery of their pharmacological properties.

However, amorfrutins and other stilbenoids bearing a carboxyl group, can be also viewed as derivatives of benzoic acid, thus belonging to the phenol carboxylic acids class. A definite classification of these pharmacologically valuable metabolites would require a sound understanding of the metabolic pathways that contribute to assembly of these compounds in Amorpha. Such a classification has not yet been attained. Elucidation of biosynthetic routes of amorfrutins is therefore eagerly needed and should include specific reactions and enzymes responsible for them as well as genes and their expression control. It is essential for understanding the mechanisms of regulation of their production and accumulation. Putatively, a combination of known pathways is involved in the construction of an amorfrutin (carboxydihydrostilbene) backbone. It could be using salicylic acid as substrate via phenylpropanoid or via isochorismate pathways, with subsequent complex addition of isoprenoid and phenylethanoid side groups. Alternatively and more likely, the biosynthetic route could also proceed via formation of stilbenecarboxylate pattern by a stilbenecarboxylate synthase (STCS) in a similar way as in hortensias or liverworts, where dihydro-4-coumaroyl-CoA is a direct substrate for lunularic acid production and the ring folding proceeds without losing a terminal carboxyl group ([@B31]). Similarly, the dihydrostilbene structure may be formed by bibenzyl synthase (BBS) activity from dihydro-4-coumaric-CoA and three molecules of malonyl-CoA ([@B90]). Both enzymes (STCS and BBS) are related to stilbene synthase (STS) but differ in catalytic specificity ([@B17]). Another possibility, although less likely, would be a formation of a stilbenoid structure via STS, then hydrogenation of the double bond linking the two aryl rings, followed by carboxylation and other substitutions of the dihydrostilbene backbone.

Among plant sources used for obtaining amorfrutins, *Glycyrrhiza foetida* Desf. roots seem to be more abundant in these metabolites ([@B122]). However, Amorpha seeds which contain about 1.5% of total prenylated carboxydihydrostilbenoids could represent a sustainable and easy to process resource for drug leads or phytomedicinal preparations for use in diabetes. An extensive screening of amorfrutin content in various populations and investigation of factors that regulate their accumulation to constant quantities would be beneficial for evaluating the possibility of using this plant as alternate industrial crop.

A report by [@B16] demonstrates significant variations in amorfrutin content between samples from different locations in China. Using HPLC, it was shown that *A. fruticosa* seeds contain between 2.6 mg/g up and 15.6 mg/g of amorfrutin A, B, and C in sum. The same team has also established a preparative method using HSCCC separation to recover a total of around 100 mg high purity amorfrutins from 100 g of seeds ([@B15]). These results suggest *A. fruticosa* seeds as feasible material for obtaining larger amounts of amorfrutins for further investigations.

It is noteworthy that a reliable universal method for determination of possibly all potentially bioactive metabolites, including rotenoids and prenyl-stilbenoids is still not available and is particularly awaited.

Phytochemical Constituents of *Amorpha fruticosa*: Volatile Constituents of Essential Oil
=========================================================================================

Both leaves and the untypical fruits with one seeded pods contain a significant volatile fraction, consisting mainly of sesquiterpenoids, both hydrocarbons and oxygenated forms. Depending on the precise location where the plant material has been collected, various compounds are reported as major ([@B38]; [@B73]). Some of the major sesquiterpenes are listed in **Table [3](#T3){ref-type="table"}**, and shown in **Figure [3](#F3){ref-type="fig"}**.

For example, in essential oil from fruit, γ-, and δ-cadinenes (**86, 87**), β-elemol (**88**) and β-caryophyllene predominated in samples from Bulgaria and Romanian Moldova ([@B106]; [@B50]), while γ-muurolene and ar-curcumene (**90**) or α-pinene and myrcene were most abundant in samples from Poland ([@B73]). The leaf oil contains mainly α-eudesmol, (E)-β-ocimene, and α-pinene ([@B73]). An uncommon cadinene stereoisomer named (-)γ-amorphene (**89**) was isolated and identified from samples collected in Ukraine. This compound, although characteristic to this plant, has been detected in small (ca.5--6% of total oil) amounts only and accompanies other cadinene-type stereoisomers ([@B79]; [@B38]).

The yield of essential oil from leaves reaches 0.23% and from fruits as much as 1.1%. The essential oil has a pleasant scent due to the mixture of highly aromatic terpenoids. However, its inconsistent composition is a limitation for its use in aromatherapy and as a medication. More research is needed to elucidate the mechanisms of this diversity and regulation of volatile organic compounds production and accumulation.

Volatile organic compounds in headspace as well as ultrasonic extracts of unifloral *A. fruticosa* bee honey were also analyzed and a number of aroma compounds identified, none of which was, however, unique for Amorpha honey. Also 2-phenylethanol, linalool oxide and a few benzoic acid esters were present as major compounds. However, the significance of this study to extrapolate to nectar composition is somewhat limited, since in honey most of the constituents could form during processing by bees or during storage and therefore, do not necessarily reflect the nectar composition ([@B52]).

Phytochemical Constituents of *Amorpha fruticosa*: Fatty Acids and Carbohydrates
================================================================================

In fatty oil extracted by supercritical CO~2~ fluid from *A. fruticosa* seeds, linoleic (66.4%) and oleic acid (11.95%) predominated whereas stearic and palmitic acid were the only saturated ones present in significant amounts (both 7%). None of the remaining 18 detected acids exceeded 1% and the extraction efficiency was 7.5% of the seeds mass ([@B121]).

A single report on polysaccharides from seeds of *A. fruticosa* indicates 2.6% content of galactomannane consisting of [D]{.smallcaps}-mannose and [D]{.smallcaps}-galactose in a ratio of 1.63:1, in which the main chain is built of 1→4-β-[D]{.smallcaps}-mannopyranose monomers with single α-[D]{.smallcaps}-galactopyranose residues attached ([@B75]).

Pharmacological Activity of *Amorpha fruticosa*: Antidiabetic Properties
========================================================================

The most studied pharmacological effect of *A. fruticosa* is its antidiabetic effect. In the recent years, metabolic diseases such as diabetes type 2 have developed to the scale of a global epidemic ([@B103]). The nuclear receptor PPARγ is a key regulator of lipid and glucose metabolism and has proved to be a viable therapeutic molecular target. However, although highly effective, currently used PPARγ-targeting drugs applied in clinics are having unwanted side effects, and this is why safer PPARy-targeting drugs are being sought. After food intake, PPARγ activity is modulated by binding of lipid food constituents, which can act as PPARγ ligands, among others unsaturated fatty acids, overall resulting in changes of the expression of a large number of metabolism-related genes ([@B122]). Interestingly, many compounds derived from medicinal foods or dietary spices also display PPARγ-activating properties ([@B5]; [@B89]; [@B120]). To identify new food-derived PPARγ-activating compounds, researchers from Germany ([@B122]) examined a natural products library of approximately 8000 molecules derived largely from edible biomaterials. As a result of this focused effort, amorfrutins were found, a structurally new class of highly potent PPARγ ligands. Amorfrutins have been present in this compound library focused on edible materials since these compounds are present in the fruits of *Amorpha fruticosa*, which are used as an ingredient in some condiments. The PPARγ receptor binding affinity constants of studied amorfrutins ranged from 236 to 354 nM, revealing a several-fold greater potency than a synthetic clinically used drug (pioglitazone) that was used as a positive control. Some of the studied amorfrutins were also able to act as less potent activators of other PPAR isoforms, PPARα and PPARβ/δ ([@B122]). In the same study, the researchers also tested for *in vivo* effectiveness a chemically synthesized amorfrutin 1 using insulin resistant high-fat diet-induced obesity (DIO) mice model. Application of amorfrutin 1 for 23 days, resulted in significant reduction of insulin resistance, similar to the reduction observed with the clinically used drug rosiglitazone. Glucose tolerance and insulin sensitivity were also enhanced, as revealed by oral glucose tolerance and intraperitoneal insulin sensitivity tests. Plasma triglycerides, insulin, free fatty acids, and glucose were reduced to an extent comparable to the positive control, rosiglitazone. Interestingly, in contrast to rosiglitazone, amorfrutin 1 also significantly reduced weight gain. Authors also studied the antidiabetic effects of amorfrutin 1 in leptin receptor-deficient db/db mice, and found that the compound was able to decrease plasma insulin levels even more potently than rosiglitazone, and also prevented the deterioration of pancreatic functionality. In summary, the results from the investigation of [@B122], suggested that amorfrutins are selective PPARγ modulators with anti-diabetic properties and overall have a more favorable bioactivity profile than the synthetic clinically used PPARγ agonists from the thiazolidinedione class.

Moreover, amorfrutins, isolated from *A. fruticosa*, are shown to act as inhibitors of the nuclear transcription factor-κB (NF-κB) signaling pathway by blocking NF-κB/DNA binding ([@B24]). This bioactivity is of high relevance, because NF-κB is a key regulator of inflammation, and the pro-inflammatory NF-κB activation contributes to the pathogenesis of diabetes, which overall might suggest that anti-inflammatory effects of amorfrutins may potentially be also implied in their antidiabetic action.

In addition to amorfrutins other compounds present in *A. fruticosa* have been evaluated for their potential as antidiabetic agents. In this context, the effects of amorphastilbol (APH), another constituent from *A. fruticosa*, was studied *in vitro* with 3T3-L1 adipocytes, as well as *in vivo* with db/db and high-fat-diet (HFD) mice ([@B68], [@B69]). It was observed that the compound is able to stimulate the transcriptional activities of PPARγ and PPARα, resulting in beneficial effects on the metabolism of lipids and glucose without significant side effects that are notoriously associated with stimulation of the PPAR receptors, such as weight gain or hepatomegaly. APH was also able to improve insulin sensitivity via inhibition of protein tyrosine phosphatase 1B ([@B69]).

Also 5,7-dihydroxy-6-geranylflavanone, another constituent from *A. fruticosa*, is reported to act as PPARα/PPARγ dual activator, being able to stimulate adipocyte differentiation of 3T3-L1 cells ([@B70]).

Pharmacological Activity of *Amorpha fruticosa*: Anti-Inflammatory And Anti-Tumor Activities
============================================================================================

The NF-κB pathway controls many physiological processes, including apoptosis, inflammatory responses, and angiogenesis. Amorfrutin A from the fruits of *A. fruticosa* was identified as a NF-κB inhibitor ([@B99]) suppressing TNF-α-activated IκBα degradation, NF-κB p65 subunit nuclear translocation, and the NF-κB DNA-binding. Moreover, it potentiated TNF-α-induced (NF-κB signaling mediated) apoptosis. This activity pattern suggests the compound as an anti-inflammatory lead and might help to rationalize some of the uses of *A. fruticosa* in traditional herbal medicine ([@B99]).

As discussed above, amorfrutins were shown to be potently acting ligands of PPARγ. [@B35] studied PPARγ-related anti-inflammatory effects of amorfrutins colon cells. Indeed it was observed that amorfrutin A reduces the expression of several inflammation mediators, at least in part due to activation of PPARγ. This activity pattern suggests amorfrutins are promising molecules with potential application in the treatment of inflammatory bowel disease or other inflammation-associated disorders.

Pharmacological Activity of *Amorpha fruticosa*: Cytotoxicity
=============================================================

The toxic potential of extracts and biologically active substances (BAS) from *Amorpha fruticosa* was evaluated principally by *in vitro* methods. [@B71] isolated eight cytotoxic compounds from a CHCl~3~ extract of *A. fruticosa*. One of these compounds, 6′-*O*-[D]{.smallcaps}-beta-glucopyranosyldalpanol, was described as a new cytotoxic rotenoid. Another known rotenoid, 12 alpha beta-hydroxyamorphigenin, was shown to exhibit extremely potent cytotoxicity (ED50 \< 0.001 μg/ml) in six neoplastic cell lines.

As a part of screening studies for cytotoxic agents (anti-tumor-promoters), six North American plants belonging to the *Amorpha* genus were tested using an *in vitro* assay ([@B64]). Authors found that *A. fruticosa* exhibited strong inhibitory effects on Epstein-Barr virus early antigen (EBA-EA) activation induced by 12-*O*-tetradecanoylphorbol-13-acetate. Six rotenoids, were isolated from the leaves of *A. fruticosa*, among which were amorphispironone and tephrosin. Apart from inhibition of EBA-EA activation, these compounds also displayed anti-tumor effects on mouse skin *in vivo*.

Eight rotenoid glycosides, including four new rotenoid glycosides, namely amorphasides, along with four known ones, all of them isolated from the seeds of *A. fruticosa* were evaluated for *in vitro* cytotoxicity against the MCF-7 and HCT-116 tumor cell lines ([@B127]). Three of the investigated substances had no effect on cell proliferation for the two cell lines even applied at 50 μM. Three other compounds had selective cytotoxicity against MCF-7. The other two compounds both displayed cytotoxicity to the two cell lines with IC~50~ values of less than 2.00 μM, which was even superior to the effect of cisplatin ([@B127]). Also rotenoids and their derivatives, being present as dominant substances in the crude extract of fruits from *A. fruticosa*, displayed significant cytotoxicity when tested against the L5178Y mouse lymphoma cell line in concentrations between 0.2 and 10.2 μM ([@B81]).

Pharmacological Activity of *Amorpha fruticosa*: Antimicrobial (Antibacterial and Antifungal) Activity and Wound Healing Effects
================================================================================================================================

Microbial pathogens are known to delay wound healing ([@B74]). *A. fruticosa* leaves and fruits have been used for treating wounds in traditional medicine. Interestingly, some constituents of *A. fruticosa* have antimicrobial potentials, thus promoting wound healing ([@B92]). Some of the compounds stimulated proliferation and migration of fibroblasts, a key cell type involved in wound healing ([@B45]; [@B92]), and also collagen synthesis was improved upon topical application of ointment containing some of the compounds isolated from *A. fruticosa* (10% w/w). In the same study, the inhibitory effects of seven compounds isolated from the fruits of *A. fruticosa* on some Gram positive and Gram negative bacteria growth were also evaluated. Three of the seven isolated compounds, including the two that also promoted wound healing showed effective Minimal Inhibitory Concentrations (MIC) and Minimum Bactericidal Concentrations (MBC) of compounds against *Bacillus subtilis, Staphylococcus aureus, Pseudomonas aeruginosa, Bacillus cerculences, Escherichia coli*, and *Klebsiella pneumonia* in a range between 0.1 and 0.2 mg/ml. These results suggest suggested that the three identified substances with rotenoid structures might be an important contributor to the wound promoting effects of *A. fruticosa*.

Antimicrobial activity of seeds from *A. fruticosa* from the Mississippi river basin was assessed as moderately effective, mainly against *S. aureus* ([@B9]). Essential oils from *A. fruticosa* fruits were found to exhibit moderate antimicrobial activity against Gram-positive bacteria ([@B50]). In another study to elucidate antibacterial properties of *A. fruticosa*, several geranylated bibenzyl compounds extracted from *A. fruticosa* fruits, exhibited significant antibacterial activity against Gram-positive bacteria ([@B81]).

Four flavanones and three rotenoids obtained via activity-guided isolation from an acetone extract of *A. fruticosa* roots (amoradicin, amorisin, isoamoritin, amoricin, amorphigeni, dalbinol, and 6-ketodehydroamorphigenin) showed strong neuraminidase inhibition *in vitro*. Some pathogens, e.g., *Haemophilus influenza* ([@B41]) or *Streptococcus pneumoniae* ([@B30]), require neuraminidase in order to proliferate. In particular, one of the compounds, amorisin, exhibited more potent inhibition (IC~50~ = 0.12 μM) than the reference compound, quercetin ([@B61]). To challenge their promising *in vitro* results, the authors then tested the isolated compounds against living bacteria in a straightforward biofilm-assay, since it is known that neuraminidase plays an important role in biofilm formation ([@B104]). The authors were able to show that two of the seven compounds were able to inhibit biofilm formation in micromolar concentrations without showing toxicity to the cells.

Pharmacological Activity of *Amorpha fruticosa*: Antioxidant and Acetylcholinesterase Inhibition Properties
===========================================================================================================

DPPH radical scavenging activity of *A. fruticosa* seeds from the Mississippi river basin was reported ([@B9]). This effect was also supported by another study, where in order to discover new natural sources for treatment of neurodegenerative disorders, methanol extracts from leaves and fruits of *A. fruticosa* were investigated for their antioxidant and acetylcholinesterase inhibitory activity ([@B128]). While both methanolic extracts showed activity, the fruit extract demonstrated higher antioxidant activity in two different assays (DPPH radical scavenging activity, ABTS radical scavenging assay), while having a lower number of total polyphenols. The determined IC~50~-values for antioxidant activity were in the low μg/ml range and superior to the positive control butylated hydroxytoluene (BHT), but acetylcholinesterase inhibitory activity of both extracts was lower than that of the positive control galantamine hydrobromide. In conclusion, *A. fruticosa* could be a useful source for agents useful for the therapy of free radical production-associated pathologies.

Pharmacological Activity of *Amorpha fruticosa*: Hepatoprotective Effects
=========================================================================

[@B27] studied the protective potential of a new amorphigenin glycoside (**Table [1](#T1){ref-type="table"}** -- compound **22**, **Figure [1](#F1){ref-type="fig"}**) against acetaminophen-induced hepatotoxicity by measuring relevant biochemical markers of hepatic injury such as alanine aminotransferase (ALT), aspartate aminotransferase (AST) and hepatic glycogen. It was found this compound could protect liver from hepatotoxicity induced by acetaminophen (AAP). Further hepatoprotective properties of *A. fruticosa*, independent of amorphigenin glycoside, might be due to the described above antioxidant effects of this plant.

Pharmacological Activity of *Amorpha fruticosa*: Osteoclast Inhibitory Effect
=============================================================================

Among other rotenoids, amorphigenin was isolated from the leaves of *A. fruticosa* and was shown to have broad anti-proliferative and anti-tumor effects in diverse cell models ([@B60]). Amorphigenin abolishes RANKL-induced osteoclast differentiation of bone marrow-derived macrophages by down-regulation of c-fos and NFATc1, without affecting cell viability ([@B60]). The compound also abolishes RANKL-induced p38 and NF-κB activation. Moreover, amorphigenin protected against LPS-induced bone loss as revealed by micro-CT analysis of the femurs in mice. Overall these results suggest that amorphigenin has a therapeutic potential in the context of inflammation-induced bone loss.

Pharmacological Activity of *Amorpha fruticosa*: Insect Repellent and Insecticidal Activity
===========================================================================================

Studies from the 1940s showed that extracts of *A. fruticosa* have repellent and insecticidal activity against diverse insect species ([@B12],[@B13]). The acetone extract of *A. fruticosa* seeds had stronger insecticidal activity against *Aedes aegypti* larvae than 1% pure rotenone ([@B13]). Ethanol extract of *A. fruticosa* seeds has demonstrated good contact effects and antifeedant activity against *Schizaphis graminum* ([@B53]). Larvicidal activity of extracts and of amorphigenin, isolated from *A. fruticosa* seeds against early fourth-instar larvae of the mosquito *Culex pipiens pallens* was also investigated ([@B72]). It was found that amorphigenin decreased mitochondrial complex I activities and the protein content. The authors concluded that amorphigenin could be a good candidate for a natural, effective and safe agent that might be used in population control of *C. pipiens pallens.*

In another work, the inhibitory action of amorphigenin against the mitochondrial complex I of *C. pipiens pallens* was studied in comparison to rotenone ([@B76]). It was observed that both compounds abolish mitochondrial complex I activity *in vitro* and *in vivo.* Mixed-I type inhibition of the mitochondrial complex I of *C. pipiens pallens* was observed, suggesting that both compounds are able to bind not just the enzyme but also the enzyme-substrate complex.

Pharmacological Activity of *Amorpha fruticosa*: Toxicity
=========================================================

All studies listed above show that BASs isolated from *A. fruticosa* are toxic for some microorganisms and some insects. In fact, this selective toxicity might be helpful for macro-organisms and human beings. Until now there are no published data about human toxicity of *A. fruticosa.* On the contrary, *A. fruticosa* and compounds isolated from it showed many positive and useful effects for humans.

Conclusion
==========

The different effects of *Amorpha fruticosa* reviewed in this work are outlined in **Figure [4](#F4){ref-type="fig"}**. The potential of *Amorpha fruticosa* against diabetes and metabolic disease is promising and deserves further investigation. The toxicity review in relation to safety application revealed that until now there are no published data about human toxicity of *A. fruticosa.* On the contrary *A. fruticosa* and compounds isolated from it showed many positive and useful effects for humans. This aggressive invasive species provides endless, cheap resource which can be utilized for remedial purposes. A vast use of *A. fruticosa* substances in the future might contribute to resolve problems associated with this aggressive invasive species in the natural habitats in many European countries.

![Outline of the different bioeffects of *Amorpha fruticosa* reviewed in this work.](fphar-08-00333-g004){#F4}
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